Proteomic Profiling of the Dystrophin-Deficient MDX Heart Reveals Drastically Altered Levels of Key Metabolic and Contractile Proteins
暂无分享,去创建一个
[1] B. Garcia,et al. Proteomics , 2011, Journal of biomedicine & biotechnology.
[2] K. Ohlendieck,et al. Drastic increase of myosin light chain MLC-2 in senescent skeletal muscle indicates fast-to-slow fibre transition in sarcopenia of old age. , 2009, European journal of cell biology.
[3] B. Chazotte. Labeling mitochondria with fluorescent dyes for imaging. , 2009, Cold Spring Harbor protocols.
[4] Pamela K. Mason,et al. Lamin A/C deficiency as a cause of familial dilated cardiomyopathy , 2009, Current opinion in cardiology.
[5] C. Hoppel,et al. Mitochondria in the human heart , 2009, Journal of bioenergetics and biomembranes.
[6] S. Wilton,et al. Proteomic profiling of antisense‐induced exon skipping reveals reversal of pathobiochemical abnormalities in dystrophic mdx diaphragm , 2009, Proteomics.
[7] E. Niggli,et al. Pathways of abnormal stress-induced Ca2+ influx into dystrophic mdx cardiomyocytes. , 2009, Cell calcium.
[8] G. Radda,et al. Abnormal cardiac morphology, function and energy metabolism in the dystrophic mdx mouse: an MRI and MRS study. , 2008, Journal of molecular and cellular cardiology.
[9] C. Hoppel,et al. Proteomics of mitochondrial inner and outer membranes , 2008, Proteomics.
[10] P. Iversen,et al. Effective rescue of dystrophin improves cardiac function in dystrophin-deficient mice by a modified morpholino oligomer , 2008, Proceedings of the National Academy of Sciences.
[11] J. D’hooge,et al. Long-term blinded placebo-controlled study of SNT-MC17/idebenone in the dystrophin deficient mdx mouse: cardiac protection and improved exercise performance , 2008, European heart journal.
[12] S. Eaton,et al. The iron-sulfur cluster of electron transfer flavoprotein-ubiquinone oxidoreductase is the electron acceptor for electron transfer flavoprotein. , 2008, Biochemistry.
[13] A. Messina,et al. Structure of the voltage dependent anion channel: state of the art , 2008, Journal of bioenergetics and biomembranes.
[14] M. Grounds,et al. Towards developing standard operating procedures for pre-clinical testing in the mdx mouse model of Duchenne muscular dystrophy , 2008, Neurobiology of Disease.
[15] S. Colan,et al. Characteristics and outcomes of cardiomyopathy in children with Duchenne or Becker muscular dystrophy: a comparative study from the Pediatric Cardiomyopathy Registry. , 2008, American heart journal.
[16] Melanie Y. White,et al. Mitochondria: A mirror into cellular dysfunction in heart disease , 2008, Proteomics. Clinical applications.
[17] M. Hecker,et al. A proteome map of murine heart and skeletal muscle , 2008, Proteomics.
[18] E. Hoffman,et al. Dystrophin-deficient cardiomyopathy in mouse: Expression of Nox4 and Lox are associated with fibrosis and altered functional parameters in the heart , 2008, Neuromuscular Disorders.
[19] K. Davies,et al. A combined metabolomic and proteomic investigation of the effects of a failure to express dystrophin in the mouse heart. , 2008, Journal of proteome research.
[20] M. Fayaz,et al. Prevalence of cardiomyopathy in Duchenne and Becker's muscular dystrophy. , 2008, Journal of Ayub Medical College, Abbottabad : JAMC.
[21] K. Ohlendieck,et al. Proteomic profiling of animal models mimicking skeletal muscle disorders , 2007, Proteomics. Clinical applications.
[22] J. Dyck,et al. Metabolic and signaling alterations in dystrophin-deficient hearts precede overt cardiomyopathy. , 2007, Journal of molecular and cellular cardiology.
[23] J. Ervasti. Dystrophin, its interactions with other proteins, and implications for muscular dystrophy. , 2007, Biochimica et biophysica acta.
[24] E. McNally. New approaches in the therapy of cardiomyopathy in muscular dystrophy. , 2007, Annual review of medicine.
[25] J. Metzger,et al. Cardiomyopathy of Duchenne muscular dystrophy: pathogenesis and prospect of membrane sealants as a new therapeutic approach , 2007, Expert review of cardiovascular therapy.
[26] M. Mann,et al. In-gel digestion for mass spectrometric characterization of proteins and proteomes , 2006, Nature Protocols.
[27] A. Fisher,et al. Targeted disruption of peroxiredoxin 6 gene renders the heart vulnerable to ischemia-reperfusion injury. , 2006, American journal of physiology. Heart and circulatory physiology.
[28] D. Duan. Challenges and opportunities in dystrophin-deficient cardiomyopathy gene therapy. , 2006, Human molecular genetics.
[29] M. Ünlü,et al. Two-dimensional difference gel electrophoresis , 2006, Nature Protocols.
[30] Marco Grzegorczyk,et al. Statistics for Proteomics: A Review of Tools for Analyzing Experimental Data , 2006, Proteomics.
[31] H. Jockusch,et al. Proteome analysis of the dystrophin‐deficient MDX diaphragm reveals a drastic increase in the heat shock protein cvHSP , 2006, Proteomics.
[32] David S. Rogers,et al. Changes in the rat heart proteome induced by exercise training: Increased abundance of heat shock protein hsp20 , 2006, Proteomics.
[33] K. Ohlendieck,et al. Reduced expression of regucalcin in young and aged mdx diaphragm indicates abnormal cytosolic calcium handling in dystrophin-deficient muscle. , 2006, Biochimica et biophysica acta.
[34] S. Winder,et al. Sparks, signals and shock absorbers: how dystrophin loss causes muscular dystrophy. , 2006, Trends in cell biology.
[35] M. Dunn,et al. The human heart proteome: Two‐dimensional maps using narrow‐range immobilised pH gradients , 2006, Electrophoresis.
[36] Kathryn S Lilley,et al. Maximising sensitivity for detecting changes in protein expression: Experimental design using minimal CyDyes , 2005, Proteomics.
[37] J. Tidball,et al. Cardiomyopathy in dystrophin-deficient hearts is prevented by expression of a neuronal nitric oxide synthase transgene in the myocardium. , 2005, Human molecular genetics.
[38] R. Marouga,et al. The development of the DIGE system: 2D fluorescence difference gel analysis technology , 2005, Analytical and bioanalytical chemistry.
[39] X. Qian,et al. Proteomic analysis of mitochondrial proteins in cardiomyocytes from chronic stressed rat , 2004, Proteomics.
[40] M. Poot,et al. Efficacy of MitoTracker Green™ and CMXrosamine to measure changes in mitochondrial membrane potentials in living cells and tissues , 2004, Cytometry. Part A : the journal of the International Society for Analytical Cytology.
[41] K. Ohlendieck,et al. Subproteomics analysis of Ca2+‐binding proteins demonstrates decreased calsequestrin expression in dystrophic mouse skeletal muscle , 2004 .
[42] B. Wong,et al. Evolution of the mdx mouse cardiomyopathy: physiological and morphological findings , 2004, Neuromuscular Disorders.
[43] K. Ohlendieck,et al. Drastic reduction in the luminal Ca2+ -binding proteins calsequestrin and sarcalumenin in dystrophin-deficient cardiac muscle. , 2004, Biochimica et biophysica acta.
[44] P. Andrews,et al. Proteomic analysis of mdx skeletal muscle: Great reduction of adenylate kinase 1 expression and enzymatic activity , 2003, Proteomics.
[45] F. Muntoni. Cardiomyopathy in muscular dystrophies , 2003, Current opinion in neurology.
[46] S. Harper,et al. Microdystrophin Gene Therapy of Cardiomyopathy Restores Dystrophin-Glycoprotein Complex and Improves Sarcolemma Integrity in the Mdx Mouse Heart , 2003, Circulation.
[47] L. Kunkel,et al. Muscular dystrophies: genes to pathogenesis. , 2003, Current opinion in genetics & development.
[48] D. Szczesna. Regulatory light chains of striated muscle myosin. Structure, function and malfunction. , 2003, Current drug targets. Cardiovascular & haematological disorders.
[49] J. Finsterer,et al. The Heart in Human Dystrophinopathies , 2003, Cardiology.
[50] J. Otero,et al. Electrocardiographic findings in mdx mice: A cardiac phenotype of Duchenne muscular dystrophy , 2002, Muscle & nerve.
[51] A. Nakamura,et al. Progression of dystrophic features and activation of mitogen‐activated protein kinases and calcineurin by physical exercise, in hearts of mdx mice , 2002, FEBS letters.
[52] H. Brunner. Annual Review of Genomics and Human Genetics , 2001, European Journal of Human Genetics.
[53] L. Kadaja,et al. Lack of dystrophin is associated with altered integration of the mitochondria and ATPases in slow-twitch muscle cells of MDX mice. , 2001, Biochimica et biophysica acta.
[54] T. Rabilloud,et al. A comparison between Sypro Ruby and ruthenium II tris (bathophenanthroline disulfonate) as fluorescent stains for protein detection in gels , 2001, Proteomics.
[55] E. Olson,et al. Calsarcins, a novel family of sarcomeric calcineurin-binding proteins. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[56] K. Campbell,et al. Molecular basis of muscular dystrophies , 2000, Muscle & nerve.
[57] M. Fukuda,et al. Regulation of Cellular Functions by Nucleoside Diphosphate Kinases in Mammals , 2000, Journal of bioenergetics and biomembranes.
[58] G. Radda,et al. Decreased myocardial nNOS, increased iNOS and abnormal ECGs in mouse models of Duchenne muscular dystrophy. , 1999, Journal of molecular and cellular cardiology.
[59] L. Kunkel,et al. Dystrophies and heart disease. , 1997, Current opinion in cardiology.
[60] M. Poot,et al. Analysis of mitochondrial morphology and function with novel fixable fluorescent stains. , 1996, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[61] J. Bobet,et al. Contractile properties of myocardium are altered in dystrophin-deficient mdx mice , 1996, Journal of the Neurological Sciences.
[62] J. Lefaucheur,et al. Phenotype of dystrophinopathy in old MDX mice , 1995, The Anatomical record.
[63] L. Kunkel,et al. The structural and functional diversity of dystrophin , 1993, Nature Genetics.
[64] E A Barnard,et al. The molecular basis of muscular dystrophy in the mdx mouse: a point mutation. , 1989, Science.
[65] S. Dimauro,et al. Duchenne muscular dystrophy: Deficiency of dystrophin at the muscle cell surface , 1988, Cell.
[66] Eric P. Hoffman,et al. Dystrophin: The protein product of the duchenne muscular dystrophy locus , 1987, Cell.
[67] M. Koenig,et al. Complete cloning of the duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals , 1987, Cell.
[68] L. Bridges. The association of cardiac muscle necrosis and inflammation with the degenerative and persistent myopathy of MDX mice , 1986, Journal of the Neurological Sciences.
[69] M. M. Bradford. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.
[70] K. Ohlendieck,et al. Opposite pathobiochemical fate of pyruvate kinase and adenylate kinase in aged rat skeletal muscle as revealed by proteomic DIGE analysis , 2008, Proteomics.
[71] E. Khan,et al. Antibiotic susceptibility of pathogens isolated from patients with community-acquired respiratory tract infections in Pakistan--the active study. , 2008, Journal of Ayub Medical College, Abbottabad : JAMC.
[72] Bernard Dan,et al. Pathophysiology of duchenne muscular dystrophy: current hypotheses. , 2007, Pediatric neurology.
[73] M. Dunn,et al. Proteomics of the Heart : Unraveling Disease , 2006 .
[74] K. Ohlendieck,et al. Deficiency in Cardiac Dystrophin Affects the Abundance of the α-/β-Dystroglycan Complex , 2005, Journal of biomedicine & biotechnology.
[75] K. Ohlendieck,et al. Subproteomics analysis of Ca+-binding proteins demonstrates decreased calsequestrin expression in dystrophic mouse skeletal muscle. , 2004, European journal of biochemistry.
[76] J. Morley,et al. Brain function in Duchenne muscular dystrophy. , 2002, Brain : a journal of neurology.
[77] K. Ohlendieck,et al. Towards an understanding of the dystrophin-glycoprotein complex: linkage between the extracellular matrix and the membrane cytoskeleton in muscle fibers. , 1996, European journal of cell biology.